Form 4 Filing for Barry J. Simon

Barry J. Simon, a director at ImmunityBio, Inc. (IBRX), reported a sale of 25,000 shares of Common Stock on October 5, 2026. The sale was executed as part of a Rule 10b5-1 trading plan adopted on December 18, 2025. The shares were sold at a weighted average price of $10.7504, within a range of $10.665 to $10.78. Following this transaction, Simon Barry J. directly owns 2,777,788 shares of Common Stock. The filing details the transaction code "S" for sale and "D" for disposed, indicating a decrease in ownership. Simon Barry J. is identified as a director with no officer or ten percent owner status. The specific details of the sale, including the weighted average price and the range, are provided, with an undertaking to furnish further information upon request.